Translating RNAi Therapy for Spinocerebellar Ataxia 1 to the Clinic

被引：0
|
作者：
Keiser, Megan S. [1 ]
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
来源：
MOLECULAR THERAPY | 2016年 / 24卷
关键词：
D O I：
10.1016/S1525-0016(16)33391-3
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
583
引用
收藏
页码：S232 / S232
页数：1
相关论文
共 50 条
  • [1] Translating RNAi Therapy for Spinocerebellar Ataxia 1 (SCA1) to the Clinic
    Keiser, Megan S.
    Boudreau, Ryan L.
    Kordower, Jeffrey H.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2014, 22 : S101 - S101
  • [2] Translating Gene Therapy for Spinocerebellar Ataxia Type 1: Unforeseen Consequences in Higher Mammals
    Keiser, Megan S.
    Lucas, Timothy J.
    Smith, Geary R.
    Muehlmatt, Amy
    Ranum, Paul T.
    Stein, Joel M.
    Wolf, Ronald L.
    Gonzalez-Alegre, Pedro
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2020, 28 (04) : 217 - 217
  • [3] RNAi or overexpression: Alternative therapies for Spinocerebellar Ataxia Type 1
    Keiser, Megan S.
    Geoghegan, James C.
    Boudreau, Ryan L.
    Lennox, Kim A.
    Davidson, Beverly L.
    NEUROBIOLOGY OF DISEASE, 2013, 56 : 6 - 13
  • [4] Combinatorial Gene Therapy for Spinocerebellar Ataxia Type 1
    Keiser, Megan S.
    Carrell, Ellie M.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2019, 27 (04) : 33 - 34
  • [5] RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
    Haibin Xia
    Qinwen Mao
    Steven L Eliason
    Scott Q Harper
    Inês H Martins
    Harry T Orr
    Henry L Paulson
    Linda Yang
    Robert M Kotin
    Beverly L Davidson
    Nature Medicine, 2004, 10 : 816 - 820
  • [6] RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia
    Xia, HB
    Mao, QW
    Eliason, SL
    Harper, SQ
    Martins, IH
    Orr, HT
    Paulson, HL
    Yang, L
    Kotin, RM
    Davidson, BL
    NATURE MEDICINE, 2004, 10 (08) : 816 - 820
  • [7] Broad Therapeutic Benefit After RNAi Expression Vector Delivery to Deep Cerebellar Nuclei: Implications for Spinocerebellar Ataxia Type 1 Therapy
    Keiser, Megan S.
    Boudreau, Ryan L.
    Davidson, Beverly L.
    MOLECULAR THERAPY, 2014, 22 (03) : 588 - 595
  • [8] Approaches to physical rehabilitation of patients with type 1 spinocerebellar ataxia in the clinic YSC CMP
    Kononov, A. M.
    Sidorova, O. G.
    Kononova, S. K.
    Davydova, T. K.
    YAKUT MEDICAL JOURNAL, 2022, (01): : 38 - 41
  • [9] Adult onset spinocerebellar ataxia in a Canadian movement disorders clinic
    Kraft, S
    Furtado, S
    Ranawaya, R
    Parboosingh, J
    Bleoo, S
    McElligott, K
    Bridge, P
    Spacey, S
    Das, S
    Suchowersky, O
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2005, 32 (04) : 450 - 458
  • [10] IGF-1 as a Potential Therapy for Spinocerebellar Ataxia Type 3
    Lin, Yong-Shiou
    Cheng, Wen-Ling
    Chang, Jui-Chih
    Lin, Ta-Tsung
    Chao, Yi-Chun
    Liu, Chin-San
    BIOMEDICINES, 2022, 10 (02)
12345